2006
DOI: 10.1093/toxsci/kfl133
|View full text |Cite
|
Sign up to set email alerts
|

Obligatory Role for Complex I Inhibition in the Dopaminergic Neurotoxicity of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)

Abstract: Administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice and nonhuman primates causes a parkinsonian disorder characterized by a loss of dopamine-producing neurons in the substantia nigra and corresponding motor deficits. MPTP has been proposed to exert its neurotoxic effects through a variety of mechanisms, including inhibition of complex I of the mitochondrial respiratory chain, displacement of dopamine from vesicular stores, and formation of reactive oxygen species from mitochondrial or… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
83
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 108 publications
(87 citation statements)
references
References 41 publications
4
83
0
Order By: Relevance
“…We have demonstrated that the Ndi1 can be introduced into mammalian mitochondria as an alternative NADH dehydrogenase for the respiratory chain and is able to complement defective complex I both in cultured cells and in animals (5,8,12,14). Successful incorporation of the Ndi1 with the bovine inner mitochondrial membrane in vitro should provide us a powerful model in which to investigate FIGURE 7.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…We have demonstrated that the Ndi1 can be introduced into mammalian mitochondria as an alternative NADH dehydrogenase for the respiratory chain and is able to complement defective complex I both in cultured cells and in animals (5,8,12,14). Successful incorporation of the Ndi1 with the bovine inner mitochondrial membrane in vitro should provide us a powerful model in which to investigate FIGURE 7.…”
Section: Methodsmentioning
confidence: 99%
“…In fact, the Ndi1 expression in the substantia nigra of mouse brains has protective effects against Parkinsonian symptoms caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment (12,14). Recently, we illustrated that the expressed Ndi1 enzyme may play a dual role in rescuing complex I-deficient cells (15); one is to restore the NADH oxidase activity, and the other is to decrease oxidative damage by complex I inhibition.…”
Section: Alternative Nadh Dehydrogenases (Ndh-2)mentioning
confidence: 99%
“…We also treated neurons with MPPϩ the active metabolite of the drug 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that is known to cause Parkinson's syndrome in rodents and humans (Przedborski and Ischiropoulos, 2005). MPPϩ is an inhibitor of the respiratory chain complex-I and its toxicity has been shown to be caused by the consequent production of oxygen derived free radicals (Fallon et al, 1997;Przedborski and Ischiropoulos, 2005;Richardson et al, 2007). All of these oxidative stressors triggered a significant increase in the fraction of cells exhibiting an apoptotic nuclear morphology characterized by chromatin condensation and/or nuclear fragmentation (Fig.…”
Section: Oxidative Damage Triggers Neuronal Apoptosis Through a Mitocmentioning
confidence: 99%
“…1), which is then taken up by neurons of the substantia nigra via the dopamine transporter [3]. In cells, MPP ϩ accumulates in mitochondria and binds to complex I of the electron transport chain, resulting in the production of reactive oxygen species (ROS) by the organelle, a decline in ATP biosynthesis, and eventually the demise of the cells [6,7]. A few insecticides and herbicides that also target mitochondrial complex I have been demonstrated to induce Parkinsonism in animal models, supporting the role of environmental toxins in the neurodegeneration [4].…”
mentioning
confidence: 99%